Skip to main content
main-content

29.04.2019 | Original Paper

Time-pattern of adverse outcomes after an infection-triggered acute heart failure decompensation and the influence of early antibiotic administration and hospitalisation: results of the PAPRICA-3 study

Zeitschrift:
Clinical Research in Cardiology
Autoren:
Òscar Miró, Koji Takagi, Étienne Gayat, Víctor Gil, Pere Llorens, Francisco J. Martín-Sánchez, Javier Jacob, Pablo Herrero-Puente, Rosa Escoda, María Pilar López-Díez, Amparo Valero, Marta Fuentes, José M. Garrido, Eva Salvo, Miguel A. Rizzi, Alfons Aguirre, Lissete Travería Bécquer, Alberto Domínguez-Rodríguez, Joan Padrosa, Gemma Martínez, Mattia Arrigo, Yonathan Freund, Alexandre Mebazaa
Wichtige Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s00392-019-01481-3) contains supplementary material, which is available to authorized users.
Òscar Miró and Koji Takagi have equally contributed to this study and should both be considered as first author.

Abstract

Objective

To investigate whether patients with an acute heart failure (AHF) episode triggered by infection present different outcomes compared to patients with no trigger and the effects of early antibiotic administration (EAA) and hospitalisation.

Methods

Two groups were made according to the AHF trigger: infection (G1) or none identified (G2). The primary outcome was 13-week (91-days) all-cause mortality, and secondary outcomes were 13-week post-discharge mortality, readmission or combined endpoint. Comparisons are presented as unadjusted and adjusted (MEESSI risk score) hazard ratios (uHR/aHR) for G1 compared to G2 patients, also estimated by weeks. Stratified analysis by EAA (provided/not provided) and patient disposition (discharged/hospitalised) was performed.

Results

We included 6727 patients (G1 = 3973; G2 = 2754). The 13-week mortality uHR was 1.11 (0.99–1.25; p = 0.06; with significant increases in the first 3 weeks), and the aHR was 0.91 (0.81–1.02; p = 0.11). There were no differences in unadjusted secondary post-discharge outcomes; however, G1 outcomes significantly improved after adjustment: aHR 0.83 (0.71–0.96; p = 0.01) for mortality, 0.92 (0.84–0.99; p = 0.04) for readmission, and 0.92 (0.85–0.99; p = 0.04) for the combined endpoint. We found a differentiated effect of hospitalisation (p < 0.05 for interaction; better post-discharge readmission and combined outcomes in G1), and a trend (p = 0.06) to lower mortality in G1 patients with EAA. Additionally, there were some differences between groups in baseline and acute episode characteristics.

Conclusion

AHF triggered by infection is not associated with a higher mid-term mortality and has better post-discharge outcomes; however, the first 3 weeks are an extremely vulnerable period. Since hospitalisation could have a role in limiting adverse post-discharge events, and EAA in reducing mortality, these relationships should be prospectively explored in further studies.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Zusatzmaterial
Supplementary material 1 (DOCX 296 KB)
392_2019_1481_MOESM1_ESM.docx
Literatur
Über diesen Artikel

Neu im Fachgebiet Kardiologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Kardiologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise